← FDA Drug Approvals (Drugs@FDA)

LEVETIRACETAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT GENERICS · Approved 2016-06-02

Drug application

FDA Application #

ANDA206838

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVETIRACETAM

Generic name

Levetiracetam

Active ingredients

LEVETIRACETAM

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

JUBILANT GENERICS

First approval

2016-06-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown